References

[1] Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33(4):570-580.

[2] Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015;3:31. Published 2015 Jul 30. doi:10.1186/s40168-015-0094-5

[3] Berg G, Rybakova D, Fischer D, et al. Microbiome definition re-visited: old concepts and new challenges [published correction appears in Microbiome. 2020 Aug 20;8(1):119]. Microbiome. 2020;8(1):103. Published 2020 Jun 30. doi:10.1186/s40168-020-00875-0

[4] Deng P, Swanson KS. Gut microbiota of humans, dogs and cats: current knowledge and future opportunities and challenges. Br J Nutr. 2015;113 Suppl:S6-S17. doi:10.1017/ S0007114514002943

[5] Sherwani MA, Tufail S, Muzaffar AF, Yusuf N. The skin microbiome and immune system: Potential target for chemoprevention?. Photodermatol Photoimmunol Photomed. 2018;34(1):25- 34. doi:10.1111/phpp.12334

[6] Meason-Smith C, Diesel A, Patterson AP, et al. Characterization of the cutaneous mycobiota in healthy and allergic cats using next generation sequencing. Vet Dermatol. 2017;28(1):71-e17. doi:10.1111/vde.12373

[7] Isaiah A, Hoffmann AR, Kelley R, Mundell P, Steiner JM, Suchodolski JS. Characterization of the nasal and oral microbiota of detection dogs. PLoS One. 2017;12(9):e0184899. Published 2017 Sep 21. doi:10.1371/journal.pone.0184899

[8] Meng S, Chen B, Yang J, et al. Study of Microbiomes in Aseptically Collected Samples of Human Breast Tissue Using Needle Biopsy and the Potential Role of in situ Tissue Microbiomes for Promoting Malignancy. Front Oncol. 2018;8:318. Published 2018 Aug 17 doi:10.3389/fonc.2018.00318 Whiteside SA, Razvi H, Dave S, Reid G, Burton JP. The microbiome of the urinary tract--a role beyond infection.

[9] Burton EN, Cohn LA, Reinero CN, Rindt H, Moore SG, Ericsson AC. Characterization of the urinary microbiome in healthy dogs. PLoS One. 2017;12(5):e0177783. Published 2017 May 17. doi:10.1371/ journal.pone.0177783

[10] Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121- 141. doi:10.1016/j.cell.2014.03.011

[11] Vogtmann E, Goedert JJ. Epidemiologic studies of the human microbiome and cancer. Br J Cancer. 2016;114(3):237-242. doi:10.1038/ bjc.2015.465

[12] Gavazza A, Rossi G, Lubas G, Cerquetella M, Minamoto Y, Suchodolski JS. Faecal microbiota in dogs with multicentric lymphoma. Vet Comp Oncol. 2018;16(1):E169-E175. doi:10.1111/vco.12367

[13] Herstad KMV, Moen AEF, Gaby JC, Moe L, Skancke E. Characterization of the fecal and mucosa-associated microbiota in dogs with colorectal epithelial tumors. PLoS One. 2018;13(5):e0198342. Published 2018 May 31. doi:10.1371/ journal.pone.0198342

[14] Fleming JM, Creevy KE, Promislow DE. Mortality in north american dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death.

J Vet Intern Med. 2011;25(2):187-198. doi:10.1111/j.1939-1676.2011.0695.x

[15] Hansen K, Khanna C. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Eur J Cancer. 2004;40(6):858-880. doi:10.1016/j. ejca.2003.11.031

[16] Bronson RT. Variation in age at death of dogs of different sexes and breeds. Am J Vet Res. 1982;43(11):2057-2059.

[17] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313]. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/caac.21492

[18] Paoloni M, Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer.

[19] Schiffman JD, Breen M. Comparative oncology: what dogs and other species can teach us about humans with cancer. Philos Trans R Soc Lond

B Biol Sci. 2015;370(1673):20140231. doi:10.1098/rstb.2014.0231

[20] Coelho LP, Kultima JR, Costea PI, et al. Similarity of the dog and human gut microbiomes in gene content and response to diet. Microbiome. 2018;6(1):72. Published 2018 Apr 19. doi:10.1186/s40168-018-0450-3

[21] Song SJ, Lauber C, Costello EK, et al. Cohabiting family members share microbiota with one another and with their dogs. Elife. 2013;2:e00458. Published 2013 Apr 16. doi:10.7554/ eLife.00458

[22] Barko PC, McMichael MA, Swanson KS, Williams DA. The

Gastrointestinal Microbiome: A Review. J Vet Intern Med. 2018;32(1):9-25. doi:10.1111/jvim.14875

[23] Mondo E, Marliani G, Accorsi PA, Cocchi M, Di Leone A. Role of gut microbiota in dog and cat’s health and diseases. Open Vet J. 2019;9(3):253-258. doi:10.4314/ovj.v9i3.10

[24] Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. Role of the microbiome in human development. Gut. 2019;68(6):1108- 1114. doi:10.1136/gutjnl-2018-317503

[25] Scott AJ, Alexander JL, Merrifield CA, et al. International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut. 2019;68(9):1624-1632. doi:10.1136/ gutjnl-2019-318556

[26] Young VB. The role of the microbiome in human health and disease: an introduction for clinicians. BMJ. 2017;356:j831. Published 2017 Mar

15. doi:10.1136/bmj.j831

[27] Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804-810. doi:10.1038/ nature06244

[28] Deng P, Swanson KS. Gut microbiota of humans, dogs and cats: current knowledge and future opportunities and challenges. Br J Nutr. 2015;113 Suppl:S6-S17. doi:10.1017/ S0007114514002943

[29] Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer.

2011;12(5):504-512. doi:10.1016/ S1470-2045(10)70186-8

[30] Omori M, Maeda S, Igarashi H, et al. Fecal microbiome in dogs with inflammatory bowel disease and intestinal lymphoma. J Vet Med Sci.

2017;79(11):1840-1847 doi:10.1292/ jvms.17-0045

[31] Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120-123. doi:10.1126/ science.1224820

[32] Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800-812. doi:10.1038/ nrc3610

[33] Villeger R, Lopes A, Carrier G, et al. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?. Int J Mol Sci. 2019;20 (18):4584. Published 2019 Sep 17 doi:10.3390/ijms20184584

[34] Grice EA, Segre JA. The skin microbiome [published correction appears in Nat Rev Microbiol. 2011 Aug;9(8):626]. Nat Rev Microbiol. 2011;9(4):244-253. doi:10.1038/ nrmicro2537

[35] Buchta V Vaginal microbiome. Vaginalni mikrobiom. Ceska Gynekol. 2018;83(5):371-379.

[36] Rea K, Dinan TG, Cryan JF. Gut Microbiota: A Perspective for Psychiatrists. Neuropsychobiology. 2020;79(1):50-62. doi:10.1159/ 000504495

[37] Picardo SL, Coburn B, Hansen AR. The microbiome and cancer for clinicians. Crit Rev Oncol Hematol. 2019;141:1-12. doi:10.1016/j. critrevonc.2019.06.004

[38] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674. doi:10.1016/j.cell.2011.02.013

[39] Munger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78(21):

11451-11460. doi:10.1128/

JVI.78.21.11451-11460.2004

[40] Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14(6):453-471. doi:10.1016/j.semcancer.2004.06.009

[41] Morales-Sanchez A, Fuentes-Panana EM. Human viruses and cancer. Viruses. 2014;6(10):4047- 4079. Published 2014 Oct 23. doi:10.3390/v6104047

[42] Thaiwong T, Sledge DG, Wise AG, Olstad K, Maes RK, Kiupel M.

[43] Munday JS, Thomson NA, Luff JA. Papillomaviruses in dogs and cats.

Vet J. 2017;225:23-31. doi:10.1016/j. tvjl.2017.04.018

[44] Regalado Ibarra AM, Legendre L, Munday JS. Malignant Transformation of a Canine Papillomavirus

Type 1-Induced Persistent Oral Papilloma in a 3-Year-Old Dog.

J Vet Dent. 2018;35(2):79-95. doi:10.1177/0898756418774575

[45] Munday JS, O’Connor KI, Smits B. Development of multiple pigmented viral plaques and squamous cell carcinomas in a dog infected by a novel papillomavirus.

Vet Dermatol. 2011;22(1):104-110. doi:10.1111/j.1365-3164.2010.00913.x

[46] Chang CY, Chen WT, Haga T, et al. The Detection and Association of Canine Papillomavirus with Benign and Malignant Skin Lesions in Dogs. Viruses. 2020;12(2):170. Published 2020 Feb 3. doi:10.3390/v12020170

[47] Luff J, Mader M, Rowland P, Britton M, Fass J, Yuan H. Viral genome

integration of canine papillomavirus

16. Papillomavirus Res. 2019;7:88-96. doi:10.1016/j.pvr.2019.02.002

[48] Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol. 2011;37(1):1-14. doi:10.3109/10408 41X.2010.501760

[49] Rosadi F, Fiorentini C, Fabbri A. Bacterial protein toxins in human cancers. Pathog Dis. 2016;74(1):ftv105.

doi:10.1093/femspd/ftv105

[50] Guerra L, Cortes-Bratti X, Guidi R, Frisan T. The biology of the cytolethal distending toxins. Toxins (Basel). 2011;3(3):172-190. doi:10.3390/ toxins3030172

[51] Nougayrede JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848-851. doi:10.1126/science.1127059

[52] Cortes-Bratti X, Karlsson C, Lagergard T, Thelestam M, Frisan T. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways.

[53] Fais T, Delmas J, Serres A, Bonnet R, Dalmasso G. Impact of CDT Toxin

on Human Diseases. Toxins (Basel). 2016;8(7):220. Published 2016 Jul 15. doi:10.3390/toxins8070220

[54] Buc E, Dubois D, Sauvanet P, et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 2013;8(2):e56964. doi:10.1371/journal. pone.0056964

[55] Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut

Microbes. 2014;5(5):675-680. doi:10.416 1/19490976.2014.969989

[56] Wilson MR, Jiang Y, Villalta PW,

et al. The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019;363(6428):eaar7785. doi:10.1126/ science.aar7785

[57] Cougnoux A, Dalmasso G, Martinez R, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence- associated secretory phenotype. Gut. 2014;63(12):1932-1942. doi:10.1136/ gutjnl-2013-305257

[58] Feng Y, Mannion A, Madden CM, et al. Cytotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor (CNF) colonize laboratory macaques. Gut Pathog. 2017;9:71. Published 2017 Dec 6. doi:10.1186/s13099-017-0220-y

[59] Kurilshikov A, Wijmenga C, Fu J, Zhernakova A. Host Genetics and Gut Microbiome: Challenges and Perspectives. Trends Immunol. 2017;38(9):633-647. doi:10.1016/j. it.2017.06.003

[60] Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr. 1999;69(5):1046S-1051S. doi:10.1093/ajcn/69.5.1046s

[61] Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature. 2016;535(7610):65- 74. doi:10.1038/nature18847

[62] Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature.

2016;535(7610):75-84. doi:10.1038/ nature18848

[63] Sonnenberg GF, Monticelli LA, Alenghat T, et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science. 2012;336 (6086) :1321-1325. doi:10.1126/science.1222551

[64] Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492-506. doi:10.1038/ s41422-020-0332-7

[65] Festi D, Schiumerini R,

Birtolo C, et al. Gut microbiota and its pathophysiology in disease paradigms. Dig Dis. 2011;29(6):518-524. doi:10.1159/000332975

[66] Huang T, Wei B, Velazquez P, Borneman J, Braun J. Commensal microbiota alter the abundance and TCR responsiveness of splenic naive CD4+ T lymphocytes. Clin Immunol. 2005;117(3):221-230. doi:10.1016/j. clim.2005.09.012

[67] Khan AA, Shrivastava A,

Khurshid M. Normal to cancer microbiome transformation and its implication in cancer diagnosis. Biochim Biophys Acta. 2012;1826(2):331-337. doi:10.1016/j.bbcan.2012.05.005

[68] Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med.

2009;361(21):2066-2078. doi:10.1056/ NEJMra0804647

[69] Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. 2009;21(4):317-337 doi:10.1093/intimm/ dxp017

[70] Abt MC, Osborne LC,

Monticelli LA, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity. 2012;37(1):158-170. doi:10.1016/j.immuni.2012.04.011

[71] Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.

J Immunol Res. 2015;2015:489821. doi:10.1155/2015/489821

[72] Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond [published correction appears in Nat Rev Cancer. 2010 Aug;10(8):593]. Nat Rev Cancer. 2010;10 (6):403-414. doi:10.1038/nrc2857

[73] Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation- induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759-771. doi:10.1038/ nrc3611

[74] Wei B, Wingender G, Fujiwara D, et al. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J Immunol. 2010;184(3):1218- 1226. doi:10.4049/jimmunol.0902620

[75] Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122(1):107-118. doi:10.1016/j. cell.2005.05.007

[76] Yamamoto ML, Schiestl RH. Intestinal microbiome and lymphoma development.

Cancer J. 2014;20(3):190-194. doi:10.1097/PPO.0000000000000047

[77] Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science. 2007;317(5834):124-127. doi:10.1126/ science.1140488

[78] Zumwalde NA, Haag JD, Gould MN, Gumperz JE. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells. Breast Cancer Res. 2018;20(1):111. Published 2018 Sep 12. doi:10.1186/ s13058-018-1036-5

[79] Fanok MH, Sun A, Fogli LK,

et al. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol. 2018;138(5):1116-1125. doi:10.1016/j. jid.2017.10.028

[80] Dapito DH, Mencin A, Gwak GY, et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell. 2012;21(4):504- 516. doi:10.1016/j.ccr.2012.02.007

[81] Minamoto Y, Otoni CC, Steelman SM, et al. Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel disease. Gut Microbes. 2015;6(1):33-47. doi:10.1080/19490976.2014.997612

[82] De la Fuente M, Franchi L, Araya D, et al. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome [published correction appears in Int J Med Microbiol. 2015 May;305(3):434]. Int J Med Microbiol. 2014;304(3-4):384-392. doi:10.1016/j.ijmm.2014.01.002

[83] Vazquez-Baeza Y, Hyde ER, Suchodolski JS, Knight R. Dog and human inflammatory bowel disease rely on overlapping yet distinct dysbiosis networks. Nat Microbiol. 2016;1:16177. Published 2016 Oct 3. doi:10.1038/ nmicrobiol.2016.177

[84] Cassmann E, White R, Atherly T,

et al. Alterations of the Ileal and Colonic Mucosal Microbiota in Canine Chronic Enteropathies. PLoS One. 2016;11(2):e0147321. Published 2016 Feb 3. doi:10.1371/journal.pone.0147321

[85] Fiehn O. Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1-2):155-171.

[86] Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell. 2008;134(5):714-717. doi:10.1016/j.cell.2008.08.026

[87] Tao J, Li S, Gan RY,

Zhao CN, Meng X, Li HB. Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action. Crit Rev Food Sci Nutr. 2020;60(6):1025-1037. doi:10.1080 /10408398.2018.1555789

[88] Wang L, Liu X, Yang Q. Application of Metabolomics in Cancer Research: As a Powerful Tool to Screen Biomarker for Diagnosis, Monitoring and Prognosis of Cancer. Biomark J. (2018); 4:12. doi: 10.21767/2472-1646.100050.

[89] Miko E, Kovacs T, Sebo E, et al. Microbiome-Microbial Metabolome- Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. Cells. 2019;8(4):293. Published 2019 Mar 29. doi:10.3390/cells8040293

[90] Velmurugan G, Dinakaran V, Rajendhran J, Swaminathan K. Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease. Trends Endocrinol Metab. 2020;31(11):835-847. doi:10.1016/j.tem.2020.01.013

[91] Yang Y, Misra BB, Liang L, et al. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.

Theranostics. 2019;9(14) :4101-4114. Published 2019 May 31. doi:10.7150/ thno.35186

[92] Visconti A, Le Roy CI, Rosa F, et al. Interplay between the human gut microbiome and host metabolism. Nat Commun. 2019;10(1):4505. Published 2019 Oct 3. doi:10.1038/ s41467-019-12476-z

[93] Marcobal A, Kashyap PC,

Nelson TA, et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J. 2013;7(10):1933-1943. doi:10.1038/ ismej.2013.89Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012;486(7402):215-221. Published 2012 Jun 13. doi:10.1038/nature11209

[94] Zierer J, Jackson MA, Kastenmuller G, et al. The fecal metabolome as a functional readout of the gut microbiome. Nat Genet. 2018;50(6):790-795. doi:10.1038/ s41588-018-0135-7

[95] Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661-672. doi:10.1038/ nrmicro3344

[96] Morrison DJ, Preston T. Formation of short chain fatty acids by the

gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189-200. doi:10.1080/1949097 6.2015.1134082

[97] Encarnagao JC, Abrantes AM, Pires AS, Botelho MF. Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Cancer Metastasis Rev. 2015;34(3):465- 478. doi:10.1007/s10555-015-9578-9

[98] Reichardt N, Duncan SH, Young P, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota [published correction appears in ISME J. 2014 Jun;8(6):1352]. ISME

J. 2014;8(6):1323-1335. doi:10.1038/ ismej.2014.14

[99] Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells [published correction appears in Nature. 2014 Feb 13;506(7487):254]. Nature. 2013;504(7480):446-450. doi:10.1038/ nature12721

[100] Nepelska M, Cultrone A, Beguet-Crespel F, et al. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. PLoS One. 2012;7(12):e52869. doi:10.1371/journal.pone.0052869

[101] Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity. Curr Opin Microbiol. 2017;35:8-15. doi:10.1016/j. mib.2016.10.003

[102] Wei W, Sun W, Yu S, Yang Y, Ai L. Butyrate production from high-fiber diet protects against lymphoma tumor. Leuk Lymphoma. 2016;57(10):2401- 2408. doi:10.3109/10428194.2016.1144 879

[103] Li Q, Cao L, Tian Y, et al. Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming. Mol Cell Proteomics. 2018;17(8):1531-1545. doi:10.1074/ mcp.RA118.0 0 0752 McQuown B, Burgess KE, Heinze CR. Preliminary investigation of blood concentrations of insulin-like growth factor, insulin, lactate and β-hydroxybutyrate in dogs with lymphoma as compared with matched controls. Vet Comp Oncol. 2018;16(2):262-267. doi:10.1111/ vco.12376

[104] McQuown B, Burgess KE, Heinze CR. Preliminary investigation of blood concentrations of insulin­like growth factor, insulin, lactate and β-hydroxybutyrate in dogs with lymphoma as compared with matched controls. Vet Comp Oncol. 2018;16(2):262- 267. doi:10.1111/vco.12376

[105] Guard BC, Barr JW, Reddivari L, et al. Characterization of microbial dysbiosis and metabolomic changes in dogs with acute diarrhea. PLoS One. 2015;10(5):e0127259. Published 2015 May 22. doi:10.1371/journal. pone.0127259

[106] Igarashi H, Ohno K, Matsuki N, et al. Analysis of fecal short chain fatty acid concentration in miniature dachshunds with inflammatory colorectal polyps. J Vet Med Sci. 2017;79(10):1727-1734. doi:10.1292/ jvms.17-0165

[107] Lampe JW, Chang JL. Interindividual differences in phytochemical metabolism and disposition. Semin Cancer Biol. 2007;17(5):347-353. doi:10.1016/j. semcancer.2007.05.003

[108] Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res. 2008;52(5):507-526. doi:10.1002/ mnfr.200700326

[109] Prabhu DS, Selvam AP, Rajeswari VD. Effective anti-cancer property of Pouteria sapota leaf on breast cancer cell lines. Biochem Biophys Rep. 2018;15:39-44. Published 2018 Jun 28. doi:10.1016/j.bbrep.2018.06.004

[110] Di Ciaula A, Wang DQ, Molina-Molina E, et al. Bile Acids and Cancer: Direct and Environmental- Dependent Effects. Ann Hepatol. 2017;16(Suppl. 1: s3-105.):s87-s105. doi:10.5604/01.3001.0010.5501

[111] Dart A. Gut microbiota bile acid metabolism controls cancer immunosurveillance. Nat Rev Microbiol. 2018;16(8):453. doi:10.1038/ s41579-018-0053-9

[112] Ou J, DeLany JP, Zhang M, Sharma S, O’Keefe SJ. Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr Cancer. 2012;64(1):34-40. doi:10.1080/01635581.2012.630164

[113] Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome [published correction appears in Nature. 2014 Feb 20;506(7488):396. Hattori, Masahisa [corrected to Hattori, Masahira]]. Nature. 2013;499(7456):97- 101. doi:10.1038/nature12347

[114] Gadaleta RM, Garcia-Irigoyen O, Moschetta A. Bile acids and colon cancer: Is FXR the solution of the conundrum?. Mol Aspects Med. 2017;56:66-74. doi:10.1016/j.mam.2017.04.002

[115] Giaginis C, Karandrea D, Alexandrou P, et al. High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma. Neoplasma. 2017;64(4):633-639. doi:10.4149/ neo_2017_420

[116] Goldberg AA, Titorenko VI, Beach A, Sanderson JT. Bile acids induce apoptosis selectively in androgen­dependent and -independent prostate cancer cells. PeerJ. 2013;1:e122. Published 2013 Aug 8. doi:10.7717/ peerj.122

[117] Herstad KMV, Ronning HT, Bakke AM, Moe L, Skancke E. Changes in the faecal bile acid profile in dogs fed dry food vs high content of beef: a pilot study. Acta Vet Scand. 2018;60(1):29. Published 2018 May 11. doi:10.1186/ s13028-018-0383-7

[118] Guard BC, HonnefferJB, Jergens AE, et al. Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid-responsive chronic inflammatory enteropathy. J Vet Intern Med. 2019;33(3):1295-1305. doi:10.1111/jvim.15493

[119] Bristow P, Tivers M,

Packer R, et al. Long-term serum bile acid concentrations in 51 dogs after complete extrahepatic congenital portosystemic shunt ligation [published correction appears in J Small Anim

Pract. 2018 Jan;59(1):70]. J Small Anim Pract. 2017;58(8):454-460. doi:10.1111/ jsap.12685

[120] Kovacs T, Miko E, Ujlaki G, Sari Z, Bai P. The Microbiome as a Component of the Tumor Microenvironment.

Adv Exp Med Biol. 2020;1225:137-153. doi:10.1007/978-3-030-35727-6_10

[121] Aarnoutse R, Ziemons J, Penders J, Rensen SS, de Vos-Geelen J, Smidt ML. The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy. Int J Mol Sci. 2019;20(17):4145. Published 2019 Aug 25. doi:10.3390/ijms20174145

[122] Iida N, Dzutsev A, Stewart CA,

et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342(6161):967-970. doi:10.1126/ science.1240527

[123] Perales-Puchalt A, Perez-Sanz J, Payne KK, et al. Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J Leukoc Biol. 2018;103(5):799- 805. doi:10.1002/JLB.5HI1117-446RR

[124] Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects

of cyclophosphamide. Science. 2013;342(6161):971-976. doi:10.1126/ science.1240537

[125] Daillere R, Vetizou M, Waldschmitt N, et al. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 2016;45(4):931-943. doi:10.1016/j.immuni.2016.09.009

[126] Geller LT, Barzily-Rokni M, Danino T, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science.

2017;357(6356):1156-1160. doi:10.1126/ science.aah5043

[127] Fournier Q, Serra JC,

Williams C, Bavcar S. Chemotherapy- induced diarrhoea in dogs and its management with smectite: Results of a monocentric open-label randomized clinical trial [published online ahead of print, 2020 Jun 20]. Vet Comp Oncol. 2020;10.1111/vco.12631. doi:10.1111/ vco.12631

[128] Paulos CM, Wrzesinski C,

Kaiser A, et al. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling [published correction appears in J Clin Invest. 2007 Oct;117(10):3140]. J Clin Invest. 2007;117(8):2197-2204. doi:10.1172/ JCI32205

[129] Yi M, Yu S, Qin S, et al. Gut microbiome modulates efficacy of immune checkpoint inhibitors. J Hematol Oncol. 2018;11(1):47. Published 2018 Mar 27. doi:10.1186/ s13045-018-0592-6

[130] Postow MA, Callahan MK, Wolchok JD. Immune Checkpoint Blockade in Cancer Therapy. J Clin Oncol. 2015;33(17):1974-1982. doi:10.1200/JCO.2014.59.4358

[131] Sivan A, Corrales L, Hubert N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350(6264):1084-1089. doi:10.1126/ science.aac4255

[132] Frankel AE, Coughlin LA, Kim J, et al. Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 2017;19(10):848-855. doi:10.1016/j. neo.2017.08.004

[133] Pilla R, Suchodolski JS. The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease. Front Vet Sci. 2020;6:498. Published 2020 Jan 14. doi:10.3389/fvets.2019.00498

[134] Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25(3):377-388. doi:10.1038/ s41591-019-0377-7

[135] Taper HS, Roberfroid MB. Possible adjuvant cancer therapy by two prebiotics--inulin or oligofructose. In Vivo. 2005;19(1):201-204.

[136] Sommacal HM, Bersch VP, Vitola SP, Osvaldt AB. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double­blind clinical trial. Nutr Cancer. 2015;67(3):457-462. doi:10.1080/016355 81.2015.1004734

[137] Rentas MF, Pedreira RS, Perini MP, et al. Galactoligosaccharide and a prebiotic blend improve colonic health and immunity of adult dogs. PLoS One. 2020;15(8):e0238006. Published 2020 Aug 28. doi:10.1371/journal. pone.0238006

[138] Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol. 1998;39(3):237-238. doi:10.1016/ s0168-1605(97)00136-0

[139] Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol. 2016;22(32):7186-7202. doi:10.3748/wjg. v22.i32.7186

[140] Hassan H, Rompola M, Glaser AW, Kinsey SE, Phillips RS. Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer. Support Care Cancer. 2018;26(8):2503-2509. doi:10.1007/s00520-018-4216-z

[141] Rong J, Liu S, Hu C, Liu C. Single probiotic supplement suppresses colitis- associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis. J Gastroenterol Hepatol. 2019;34(7): 1182-1192. doi:10.1111/jgh.14516

[142] Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J

Clin Immunol. 2012;32(6):1353-1359. doi:10.1007/s10875-012-9708-x

[143] Le Noci V, Guglielmetti S,

Arioli S, et al. Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases. Cell Rep. 2018;24(13):3528- 3538. doi:10.1016/j.celrep.2018.08.090

[144] Naito S, Koga H, Yamaguchi A, et al. Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer. J Urol. 2008;179(2):485-490. doi:10.1016/j.juro.2007.09.031

[145] Osterlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 2007;97(8):1028-1034. doi:10.1038/ sj.bjc.6603990

[146] Motoori M, Yano M, Miyata H, et al. Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events

in esophageal cancer patients. Clin Nutr. 2017;36(1):93-99. doi:10.1016/j. clnu.2015.11.008

[147] Schmitz S, Suchodolski J. Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence?. Vet Med Sci. 2016;2(2):71- 94. Published 2016 Jan 11. doi:10.1002/ vms3.17

[148] White R, Atherly T, Guard B, et al. Randomized, controlled trial evaluating the effect of multi-strain probiotic

on the mucosal microbiota in canine idiopathic inflammatory bowel disease. Gut Microbes. 2017;8(5):451-466. doi:10.1080/19490976.2017.1334754

[149] Rossi G, Pengo G, Caldin M,

et al. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS One. 2014;9(4):e94699. Published 2014 Apr 10. doi:10.1371/journal. pone.0094699

[150] Xu H, Huang W, Hou Q, et al. Oral Administration of Compound Probiotics Improved Canine Feed Intake, Weight Gain, Immunity and Intestinal Microbiota. Front Immunol. 2019;10:666. Published 2019 Apr 2. doi:10.3389/fimmu.2019.00666

[151] Kao D, Roach B, Silva M, et al. Effect of Oral Capsule- vs Colonoscopy- Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA. 2017;318(20):1985-1993. doi:10.1001/ jama.2017.17077

[152] Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis.

2011;53(10):994-1002. doi:10.1093/cid/ cir632

[153] Matson V, Fessler J, Bao R, et al.

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359(6371):104-108. doi:10.1126/ science.aao3290

[154] Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97-103. doi:10.1126/ science.aan4236

[155] Pereira GQ, Gomes LA, Santos IS, Alfieri AF, Weese JS, Costa MC. Fecal microbiota transplantation in puppies with canine parvovirus infection.

J Vet Intern Med. 2018;32(2):707-711. doi:10.1111/jvim.15072

[156] Niederwerder MC. Fecal microbiota transplantation as a tool to treat and reduce susceptibility to disease in animals. Vet Immunol

Immunopathol. 2018;206:65-72. doi:10.1016/j.vetimm.2018.11.002

[157] Koyasu S, Moro K. Role of innate lymphocytes in infection

and inflammation. Front Immunol. 2012;3:101. Published 2012 May 7. doi:10.3389/fimmu.2012.00101